Cardinal Health, Inc. (NYSE:CAH) is ranked among the 20 Best Performing Dividend Stocks in 2025 due to its market-beating performance and strategic focus on specialty pharmaceuticals and managed services. Analysts forecast earnings growth of 19.3% in FY 2026 and 12.6% in FY 2027.

The company recently raised its fiscal 2026 outlook, now expecting adjusted earnings per share between $9.65 and $9.85, up from $9.30 to $9.50. The increase reflects a strong first-quarter performance and anticipates contributions from the pending acquisition of Solaris Health in early November.

Cardinal Health, Inc. operates globally in distributing pharmaceuticals, manufacturing medical supplies, and providing healthcare services. While promising as an investment, some suggest other AI stocks may offer higher upside potential with less downside risk, particularly in the current economic climate.

For more insights on pharmaceutical dividend stocks and dividend aristocrats to invest in, check out further reports from Insider Monkey.

Read more at Yahoo Finance: Cardinal Health (CAH) Repositions for Growth with Specialty and Services